HomeInsights52 Week High Stocks

Astrazeneca Pharma India Ltd 52 Week High

Astrazeneca Pharma India Ltd 52 Week High

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

YEARHIGH

₹ 8139.85

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Astrazeneca Pharma India Ltd is ₹ 8139 as of 22 Nov 24 .

Company Fundamentals for Astrazeneca Pharma India Ltd

No data available

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20246336.9
21 Nov 20246288.9
19 Nov 20246497.5
18 Nov 20246397.65
14 Nov 20246770.6
13 Nov 20247133.1
12 Nov 20247410.5
11 Nov 20247252.7
08 Nov 20247317.65
07 Nov 20247517

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca Pharma gains on plan to launch COPD drug

Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...

Read more

19 Nov 202412:11

News

AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr

Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...

Read more

14 Nov 202412:34

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 202416:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 202408:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 202412:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...

Read more

24 Sep 202414:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Astrazeneca Pharma India Ltd

What is the significance of Astrazeneca Pharma India Ltd reaching its 52-week high?

Astrazeneca Pharma India Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Astrazeneca Pharma India Ltd 52-week high?

Investors monitor Astrazeneca Pharma India Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Astrazeneca Pharma India Ltd a good buy when it hits its 52-week high?

Whether Astrazeneca Pharma India Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Astrazeneca Pharma India Ltd fundamentals.

What should I consider before investing in Astrazeneca Pharma India Ltd at its 52-week high?

Before investing in Astrazeneca Pharma India Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Astrazeneca Pharma India Ltd stock price continue to rise after reaching its 52-week high?

Astrazeneca Pharma India Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*